Xtant Medical Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Xtant Medical Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $53.34M | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | $64.68M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $72.20M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $82.61M | Apr 1, 2019 |
| FY2011 | Dec 31, 2011 | $30.15M | Mar 29, 2012 |
| FY2011 | Dec 31, 2010 | $15.42M | Mar 29, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $117.27M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $91.30M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $57.97M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $55.26M | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $53.34M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $64.68M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $72.20M | Mar 5, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $82.61M | Apr 5, 2018 |
| FY2017 | Dec 31, 2016 | $90.00M | Apr 5, 2018 |
| FY2016 | Dec 31, 2015 | $59.35M | Mar 29, 2017 |
| FY2015 | Dec 31, 2014 | $35.33M | Mar 24, 2016 |
| FY2014 | Dec 31, 2013 | $33.07M | Mar 18, 2015 |
| FY2013 | Dec 31, 2012 | $32.98M | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | $30.15M | Mar 27, 2013 |
| FY2011 | Dec 31, 2010 | $15.21M | Mar 29, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($16.45M) | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $660.0K | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($8.49M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($4.85M) | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | ($7.02M) | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | ($8.22M) | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | ($70.10M) | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | ($52.41M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($19.49M) | Apr 5, 2018 |
| FY2016 | Dec 31, 2015 | ($2.17M) | Mar 29, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($12.07M) | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | ($10.16M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($6.76M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($3.85M) | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | ($751.0K) | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | ($2.25M) | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | ($60.08M) | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | ($37.83M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($7.55M) | Apr 5, 2018 |
| FY2016 | Dec 31, 2015 | ($12.08M) | Mar 29, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $93.84M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $92.61M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $60.23M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $54.69M | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $41.47M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $43.16M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $46.42M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $105.71M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $144.10M | Apr 5, 2018 |
| FY2016 | Dec 31, 2015 | $141.03M | Mar 29, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $50.87M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $41.26M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $26.06M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $23.81M | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $26.95M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $87.36M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $90.19M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $164.40M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $151.17M | Apr 5, 2018 |
| FY2016 | Dec 31, 2015 | $132.15M | Mar 29, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $42.96M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $51.35M | Mar 6, 2025 |
| FY2024 | Dec 31, 2022 | $34.17M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $30.88M | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | $14.51M | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | ($44.21M) | Mar 8, 2022 |
| FY2020 | Dec 31, 2018 | ($43.77M) | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | ($58.70M) | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | ($7.07M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $8.88M | Apr 5, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | (5) | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | (34) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | (18) | Apr 5, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 29, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | (5) | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | (34) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | (18) | Apr 5, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 29, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $6.20M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $5.72M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $20.30M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $18.24M | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $2.34M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $5.24M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $6.80M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $2.86M | Apr 1, 2019 |
| FY2018 | Dec 31, 2016 | $2.58M | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $6.37M | Apr 5, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $22.04M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $17.17M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $9.69M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $11.79M | Mar 7, 2023 |
| FY2020 | Dec 31, 2019 | $76.24M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $77.94M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $137.96M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $119.22M | Apr 5, 2018 |
| FY2016 | Dec 31, 2015 | $110.67M | Mar 29, 2017 |